Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
02/04/2026
Fuguo Bank lowered its price target for META from $856 to $765.
Latest
3 m ago
A report jointly released by the United Nations, the African Union, and the African Development Bank pointed out that prolonging the duration of the Gulf War will cause a 0.2 percentage point decrease in Africa's GDP growth rate in 2026.
3 m ago
Chi Fei Biotech announced that the company signed a revised and restated supply, distribution, and co-promotion agreement with MSD on April 2, 2026. The original agreement will terminate upon the effectiveness of the new agreement. The new agreement aims to deepen the strategic cooperation between the two parties, enhance market synergy, address operational pressures, and includes products such as the nine-valent HPV vaccine. The cooperation period extends until the end of 2028 and may be extended for two years. The company will adjust procurement and supply quantities dynamically based on market demand, and performance under the agreement will be disclosed regularly. The new agreement no longer specifies a base purchase amount for the agreement products. Chi Fei Biotech and MSD will negotiate and confirm expected procurement and supply plans based on market expectations and actual vaccination situations. The company will then procure the agreement products on a rolling basis. Specific procurement details will be based on orders confirmed in writing by both parties.
4 m ago
Iran Revolutionary Guards Navy Headquarters: Escalation of war will expand our range of targets and accelerate the expulsion of the United States from the region. In a series of retaliatory actions against the enemy, the following targets have been hit: Abu Dhabi American Steel Industry Company, Bahrain Shide Industrial City, and the remaining aluminum industry infrastructure in Bahrain...
4 m ago
According to an AI flash news, Huaxin Securities released a research report on April 2, giving a "buy" rating to PetroChina (601857.SH). The main reasons for the rating include: 1) the dual drive of natural gas and new materials, continuous strengthening of profit resilience; 2) optimization of cost structure and increased investment in research and development, stable cash flow and financing adjustment; 3) orderly promotion of new production capacity and accelerated breakthrough in new materials. (Daily Economic News)
4 m ago
Champion Biotech: Strategic Cooperation Agreement Adjusted with MSD.
See all latest
